EUVIMEDEUVIMED entdecken
Crossref

A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel

Gili Reznick Levi, Gal Larom, Vered Ofen Glassner, Nina Ekhilevitch, Nitzan Sharon Swartzman, Tamar Paperna, Hagit Baris-Feldman, Karin Weiss

Familial Cancer · 2022-07 · 21 (3) · 289-294

DOI: 10.1007/s10689-021-00262-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Familial Cancer, online erschienen am 17.05.2021. Verfasst von Gili Reznick Levi und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Genetics Institute, Rambam Health Care Campus, Haifa, Israel. g_reznick@rambam.health.gov.il. Hauptthemen laut MEDLINE: BRCA2 Protein, Breast Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline pathogenic variants (PVs) in BRCA1/BRCA2 are well-established risk factors for breast cancer (BC) and/or ovarian cancer (OC). Founder PVs have been described in BRCA1/ BRCA2 in several genetic isolates. The Christian Arab population in the Middle East is a relatively isolated ethnic group, yet founder, or recurrent BRCA1/BRCA2 PVs have not been reported in this population. In this study we describe PVs detected in cancer susceptibility genes among a cohort of Christian Arabs from Israel. We reviewed patient records from the Oncogenetic clinic at Rambam Health Care Campus during the years 2013- mid 2020. Thirty-five unrelated Christian Arab patients, with personal or family history of BC and/or OC underwent BRCA1/BRCA2 (14/35) testing or cancer gene panel testing (21/35) as part of their diagnostic workup. Three clinically significant variants in BRCA2, CHEK2 and RAD51C were found in 7/35 patients (20%). A recurrent duplication of the BRCA2 genomic region, encompassing exons 5-10 and the 5' portion of exon 11, was found in 5/33 (15.2%) patients for whom copy number variants (CNVs) analysis was performed. We identified a recurrent pathogenic BRCA2 duplication in Christian Arab patients with a personal/ family history of BC and/or OC. Our findings emphasize the importance of inclusion of CNVs analysis in BRCA1/BRCA2 genetic testing, and specifically for Christian Arab patients suspected of hereditary BC and/or OC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinBreast NeoplasmsOvarian NeoplasmsArabsBRCA1 ProteinExonsFemaleGene DuplicationGenes, BRCA2Genetic Predisposition to DiseaseHumansIsrael

Stichwörter der Autor:innen

BRCA2Breast cancerChristian ArabDuplicationOvarian cancer

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • The Genetics Institute, Rambam Health Care Campus, Haifa, Israel. g_reznick@rambam.health.gov.il.
  • The Genetics Institute, Rambam Health Care Campus, Haifa, Israel.
  • The Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Institute of Medical Genetics, Meir Medical Center, Kfar Saba, Israel.
  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Zitieren

APA

Reznick Levi, G., Larom, G., Ofen Glassner, V., Ekhilevitch, N., Sharon Swartzman, N., Paperna, T., Baris-Feldman, H., & Weiss, K. (2022). A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel. Familial Cancer, 21(3), 289-294. https://doi.org/10.1007/s10689-021-00262-0

Vancouver

Reznick Levi G, Larom G, Ofen Glassner V, Ekhilevitch N, Sharon Swartzman N, Paperna T, et al. A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel. Familial Cancer. 2022;21(3):289-294. doi:10.1007/s10689-021-00262-0

BibTeX
@article{ReznickLevi2022,
  author = {Reznick Levi, Gili and Larom, Gal and Ofen Glassner, Vered and Ekhilevitch, Nina and Sharon Swartzman, Nitzan and Paperna, Tamar and Baris-Feldman, Hagit and Weiss, Karin},
  title = {A recurrent pathogenic BRCA2 exon 5–11 duplication in the Christian Arab population in Israel},
  journal = {Familial Cancer},
  year = {2022},
  volume = {21},
  number = {3},
  pages = {289--294},
  doi = {10.1007/s10689-021-00262-0}
}
Kostenlos starten →